Abstract
In our effort directed toward the discovery of new anti-diabetic agent for the treatment of diabetes, a library of biscoumarin derivative 1-18 was synthesized and evaluated for alpha-glucosidase inhibitory potential. All eighteen (18) compounds displayed assorted alpha-glucosidase activity with IC50 values 16.5 -385.9 mu M, if compared with the standard acarbose (IC50 = 906 +/- 6.387 mu M). In addition, molecular docking studies were carried out to explore the binding interactions of biscoumarin derivatives with the enzyme. This study has identified a new class of potent alpha-glucosidase inhibitors. (C) 2014 Elsevier Masson SAS. All rights reserved.